SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TRUMP is a politics-themed digital coin built on the Solana blockchain that uses the brand of Donald Trump to foster a community-driven ecosystem. As a community-focused asset, it is designed to bridge political support with web ownership, operating within the PolitiFi sector to blend political movements with decentralized finance tools. The project's main value proposition lies in its official ties to Donald Trump’s media and business brands, which allows it to provide unique physical utility such as invitations to gala dinners and meetings at Mar-a-Lago.  The token serves as the primary currency for the officially licensed Trump Billionaires Club mobile and web game, where it is used for in-game purchases and unlocking features. By leveraging the Solana blockchain, the project ensures that these in-game actions and token transfers remain fast and cost-effective. The ecosystem remains stable through a programmatic release schedule that introduces new tokens slowly to prevent supply shocks, alongside the use of specialized market makers to maintain consistent liquidity for traders.  Holders can also participate in liquidity sharing by providing their tokens to automated systems to facilitate trading for others, often earning rewards or prizes in return. Beyond digital utility, holding a specific amount of the token is a requirement for attending exclusive real-world events, including VIP parties at Mar-a-Lago. The project is managed by the Trump Meme Team and is linked with Trump Media, with an investor base that includes a wide range of retail buyers and large holders who utilize secure custody services for their assets.

Trump For President

Discussion centers on TRUMPs steep decline and concerns that the meme coin has left retail holders with losses, alongside accusations that insiders benefited. Bulls counter that the dip could lead to a rebound, with some speculating about a squeeze or token-unlock-related move; those catalysts are not established in the conversation.

Select Sector SPDR Trust (The) - State Street Health Care Select Sector SPDR ETF

Health Care Select Sector SPDR Fund

XLV is drawing attention as healthcare shows relative strength and attracts defensive rotation from technology and other riskier sectors, with traders citing sector inflows, gains across healthcare holdings, and technical breakouts. The tone is broadly bullish, though some traders warn the rally has been volatile and may be due for a pullback.

iShares Trust - iShares 7-10 Year Treasury Bond ETF

iShares 7-10 Year Treasury Bond ETF

Concerns about U.S. debt and fiscal pressures, alongside elevated Treasury yields and expectations for rates to stay higher for longer, dominate discussion of IEF. Traders are mostly wary of further bond weakness, though some point to Treasury demand and view intermediate-term bonds as a potential hedge or rebound opportunity.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

Geopolitical supply-disruption concerns around the Middle East, Strait of Hormuz shipping and energy infrastructure are driving attention to XLE alongside rising oil and fuel prices. Traders point to energys relative strength and bullish chart setups, while others question whether diplomacy, easing supply risks or a pullback could reverse the move.

Securitize Corp. is a financial technology company, which engages in the provision of regulated infrastructure for the issuance, management, trading, and administration of tokenized real-world assets (RWAs). The company was founded on October 17, 2025 and is headquartered in Miami, FL.

Securitize Corp.

Securitizes launch of tokenized U.S. stocks on Solana has fueled interest in its role as tokenization infrastructure, with bullish traders pointing to the products growth potential. That optimism is tempered by debate over how the company will monetize the business and by volatile trading and a sharp pullback.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

A sharp Nasdaq and technology-stock selloff, amid hotter inflation concerns, elevated yields, and pressure on AI and semiconductor shares, is driving attention to this leveraged QQQ fund. Traders are split between buying the dip for a relief bounce and warning that bearish momentum could bring further losses.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Rising crude prices amid Middle East and Strait of Hormuz supply concerns are driving attention to Chevron, with traders also highlighting its move to new highs and bullish technical momentum. Some see room for the energy rally to continue, while others warn the stock is extended and can diverge from oil-price moves.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visas fresh record highs and breakout are drawing bullish attention, with traders pointing to Chinas approval for Visa to prepare a domestic card-clearing business and its stablecoin initiatives as potential growth opportunities; the China move is only a preparatory step, with operating approval still required. Some traders caution that the rally looks stretched and are betting on a pullback.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

Northlands upgrade of C3.ai, citing its new C3 Code platform for building agentic AI applications, is driving attention. Traders see growth potential and a possible short squeeze, while skeptics point to declining revenue and the stocks sharp fade after its recent rally.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

LEU is drawing attention amid a sharp selloff, with traders pointing to past stock and warrant offerings, dilution concerns, a rich valuation, and the cost and execution risks of expanding enrichment capacity. Others argue the decline is overdone given Centruss contracts, cash position, and strategic role in the U.S. nuclear-fuel supply chain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dow, S&P 500, Nasdaq Futures Edge Higher After Fed Delivers Rate Hike: SPCX, CADL, SNAP, FLNC Stocks In Focus

Equity

The Federal Reserve On Wednesday hiked benchmark interest rates by 25 bps to a target range of 3.75% to 4.00%, in line with market expectations. 

The Zacks Analyst Blog Highlights Pfizer, Novartis, Candel and Janux 

Prostate cancer awareness spotlights Pfizer's Xtandi, Novartis' Pluvicto and clinical-stage programs from Candel and Janux.

4 Prostate Cancer Drug Stocks to Watch During Awareness Month

Pfizer, Novartis, Janux Therapeutics and Candel Therapeutics offer varied prostate-cancer exposure, with established drugs and clinical or regulatory catalysts.

CADL Rises As Biotech Eyes First Commercial Product in 2027 — CEO Points To ‘Meaningful Execution’ Toward BLA Submission In Q4

If the FDA approves aglatimagene besadenovec in the treatment of certain patients with prostate cancer, it would mark the company’s first commercial product. 


CADL Stock In Focus As Candel Nears Year-End BLA Filing For Prostate Cancer Drug —  Eyes $10–$16B Opportunity 

Shares of Candel have drawn rising attention as the company advances its experimental immunotherapy, known as CAN-2409 or aglatimagene, toward potential approval in localized prostate cancer.


CADL Stock Heads For Biggest Monthly Gains Since December 2024 – Retail Says ‘Our SLS Days Are Coming’

Candel Therapeutics announced the initiation of a Phase 3 trial evaluating lead therapy CAN-2409 in advanced non-small cell lung cancer patients.

CADL Stock Heads For Best Week In A Month – Here’s Why Retail Is Bullish

Candel Therapeutics Phase 3 prostate cancer trial showed a higher disease-free survival rate.

Wall Street Analysts Believe Candel Therapeutics (CADL) Could Rally 148.48%: Here's is How to Trade

The mean of analysts' price targets for Candel Therapeutics (CADL) points to a 148.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Candel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data

Candel Therapeutics presented positive phase 3 prostate cancer data showing improved disease-free survival, while analysts maintained bullish expectations on the stock.read more...

CADL Stock Edges Up After Hours On Strong Extended Prostate Cancer Data  

The company reported that, after a median follow-up of 58 months, CAN-2409 delivered a statistically significant 39% improvement in prostate cancer-specific disease-free survival versus placebo. 

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$8.19
Prev Close	$8.91
Open	$8.92
Dividend Yield	0.00%
50-Day Moving Average	$11.33
Beta	1.51
Avg. Volume	1.19M
PE Ratio	-5.81

52-Week High	$14.00
52-Week Low	$4.35
Market Capitalization	$626.69M
EPS (Annual)	-$0.721
Price to Book	4.94
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

CADL Fundamentals